190 related articles for article (PubMed ID: 15908843)
1. The answerable question and a hierarchy of evidence.
Hamilton J
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):596-600. PubMed ID: 15908843
[No Abstract] [Full Text] [Related]
2. Improving decision making in the treatment of ADHD.
Vitiello B
Am J Psychiatry; 2008 Jun; 165(6):666-7. PubMed ID: 18519529
[No Abstract] [Full Text] [Related]
3. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
4. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
5. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
6. Attention deficit hyperactivity disorder: part III.
Ryan-Krause P
J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
[No Abstract] [Full Text] [Related]
7. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.
Diller LH
Hastings Cent Rep; 1996; 26(2):12-8. PubMed ID: 8722521
[No Abstract] [Full Text] [Related]
8. [Atomoxetine in ADHD: caution].
Karila L
Rev Prat; 2011 Nov; 61(9 Suppl):S7-8. PubMed ID: 22338199
[No Abstract] [Full Text] [Related]
9. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
Hennessy S; Schelleman H; Daniel GW; Bilker WB; Kimmel SE; Guevara J; Cziraky MJ; Strom BL
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):934-41. PubMed ID: 20623519
[TBL] [Abstract][Full Text] [Related]
10. Question 2 Should a child with ADHD and epilepsy be given ritalin?
Boyes C
Arch Dis Child; 2010 Sep; 95(9):759-61. PubMed ID: 20716679
[No Abstract] [Full Text] [Related]
11. [The practice and problem of therapeutic agents for AD/HD].
Tanaka H; Miyajima T
No To Hattatsu; 2010 May; 42(3):213-6. PubMed ID: 23858580
[No Abstract] [Full Text] [Related]
12. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
13. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA
Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
[TBL] [Abstract][Full Text] [Related]
14. [Without treatment the crash threatens].
Einecke U
MMW Fortschr Med; 2009 Jan; 151(5):14-6. PubMed ID: 19391404
[No Abstract] [Full Text] [Related]
15. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
Olfson M; Marcus SC; Zhang HF; Wan GJ
J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
[No Abstract] [Full Text] [Related]
16. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
[TBL] [Abstract][Full Text] [Related]
17. Exposure to attention deficit hyperactivity disorder medications during pregnancy.
Humphreys C; Garcia-Bournissen F; Ito S; Koren G
Can Fam Physician; 2007 Jul; 53(7):1153-5. PubMed ID: 17872810
[TBL] [Abstract][Full Text] [Related]
18. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate euphoria.
Corrigall R; Ford T
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
[No Abstract] [Full Text] [Related]
20. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
